Lisa von Moltke, M.D.
Lisa von Moltke, M.D., is the Chief Medical Officer at Seres. She has deep experience in directing successful development programs, leading clinical teams, and interacting with regulatory agencies across multiple areas of medicine. Prior to joining Seres, Dr. von Moltke worked for Alkermes, Inc., where she served in roles of increasing seniority, culminating as Senior Vice President and Head of Clinical Development. Prior to joining Alkermes, Dr. von Moltke served as Vice President Clinical Pharmacology at Sanofi/Genzyme Corporation, where she also served as U.S. Head Clinical & Exploratory Pharmacology Sciences (CEP) and Early Development and later as Head CEP for Japan and China regions. Earlier in her career, Dr. von Moltke served as Head, Translational Medicine for the Takeda Oncology Company. She has served as President of the American College of Clinical Pharmacology and as the Editor-in-Chief of The Journal of Clinical Pharmacology. Dr. von Moltke earned a Bachelor of Arts degree at Wellesley College and her Doctor of Medicine from Michigan State University, College of Human Medicine.